ClinicalTrials.Veeva

Menu

The Study of Abatacept in Combination With Etanercept

Bristol-Myers Squibb (BMS) logo

Bristol-Myers Squibb (BMS)

Status and phase

Completed
Phase 2

Conditions

Rheumatoid Arthritis

Treatments

Drug: Abatacept

Study type

Interventional

Funder types

Industry

Identifiers

NCT00162279
IM101-101

Details and patient eligibility

About

The Study was designed to look at the safety and efficacy of abatacept in combination with etanercept.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • All subjects who had completed the short term portion of IM101-101.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

Trial contacts and locations

35

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems